Search results
Vor Biopharma’s (VOR) “Outperform” Rating Reiterated at Wedbush
ETF DAILY NEWS· 6 days agoWedbush reissued their outperform rating on shares of Vor Biopharma (NYSE:VOR – Free Report) in a research report released on Tuesday, Benzinga reports. Wedbush currently has a $11.00 price ...
How Big Pharma Is Taking A Page Out Of Novartis' Playbook
Investor's Business Daily· 7 days agoNovartis (NVS) blazed a trail for treating cancer with targeted radiopharmaceuticals, a treatment that sends radiation directly to cancer cells. Novartis' prostate cancer drug, Pluvicto, which ...
Critical Survey: Coeptis Therapeutics (COEP) versus The Competition
ETF DAILY NEWS· 7 days agoCoeptis Therapeutics (NASDAQ:COEP – Get Free Report) is one of 289 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We ...
Eagles sweep Panthers in county rematch
The Herald Bulletin· 7 days agoAt least it was dry the second time around. Less than two weeks after barely finishing their Madison County first-round match on a chilly and damp...
Kura Oncology, Inc. (NASDAQ:KURA) Stock Holdings Lessened by Mirae Asset Global Investments Co. Ltd.
ETF DAILY NEWS· 6 days agoMirae Asset Global Investments Co. Ltd. lessened its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA – Free Report) by 5.7% in the fourth quarter, according to the company in its most ...
